PSA outcomes in patients with adenocarcinoma of the prostate with presenting PSA > 20 ng/ml

被引：0
|
作者：
Shasha, Daniel
Debenham, Brock John
Salant, Robert
Harrison, Louis Benjamin
机构：
[1] Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, New York, NY 10003 USA
[2] Beth Israel Deaconess Med Ctr, Dept Urol, New York, NY 10003 USA
[3] St Lukes Roosevelt Hosp, New York, NY 10025 USA
[4] Beth Israel Deaconess Med Ctr, Continuum Canc Ctr New York, New York, NY 10003 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.241
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
241
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Outcome analysis of prostate cancer patients presenting with PSA > 50 ng/ml
    Wiebe, E.
    Rodrigues, G. B.
    Lock, M.
    D'Souza, D.
    Whiston, F.
    Stitt, L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S390 - S390
  • [2] EXTREME-RISK PROSTATE ADENOCARCINOMA PRESENTING WITH PROSTATE-SPECIFIC ANTIGEN (PSA) >40 NG/ML: PROGNOSTIC SIGNIFICANCE OF THE PRERADIATION PSA NADIR
    Alexander, Abraham S.
    Mydin, Aminudin
    Jones, Stuart O.
    Christie, Jennifer
    Lim, Jan T. W.
    Truong, Pauline T.
    Ludgate, Charles M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : E713 - E719
  • [3] DO PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR LOCALLY ADVANCED PROSTATE CANCER AND PSA >50 ng/ml HAVE A WORSE PROGNOSIS THAN PATIENTS WITH PSA>20 ng/ml?
    Marchioro, Giansilvio
    Maso, Gloria
    Vidali, Matteo
    Volpe, Alessandro
    Tarabuzzi, Roberto
    Zaramella, Stefano
    Zacchero, Monica
    De Lorenzis, Elisa
    Crivellaro, Simone
    Frea, Bruno
    Terrone, Carlo
    [J]. ANTICANCER RESEARCH, 2010, 30 (04) : 1435 - 1435
  • [4] Active surveillance in patients with a PSA > 10 ng/mL
    Toren, Paul
    Wong, Lih-Ming
    Timilshina, Narhari
    Alibhai, Shabbir
    Trachtenberg, John
    Fleshner, Neil
    Finelli, Antonio
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2014, 8 (9-10): : E702 - E707
  • [5] IS PSA VELOCITY USEFUL FOR PROSTATE CANCER DETECTION OR PROGNOSTICATION IN MEN WITH A PSA > 10 NG/ML?
    Loeb, Stacy
    Roehl, Kimberly A.
    Catalona, William J.
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 811 - 811
  • [6] SURGICAL AND ONCOLOGICAL OUTCOMES IN PATIENTS WITH A PREOPERATIVE PSA VALUE >20 NG/ML UNDERGOING ROBOTIC PROSTATECTOMY
    Zugor, V.
    Labanaris, A. P.
    Porres, D.
    Addali, M.
    Witt, J. H.
    [J]. ANTICANCER RESEARCH, 2011, 31 (05) : 2009 - 2009
  • [7] Outcome analysis of prostate cancer patients presenting with PSA >50 Ng/MI
    Wiebe, E.
    Rodrigues, G.
    Lock, M.
    Dsouza, D.
    Whiston, F.
    Stitt, L.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S34 - S34
  • [8] Risk of prostate cancer death and progression in patients with preoperative PSA >20 ng/ml undergoing radical prostatectomy
    Zwergel, UE
    Lehmann, J
    Hack, M
    Kamradt, J
    Wullich, B
    Stöckle, M
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 312 - 312
  • [9] Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?
    Seung Hwan Lee
    Mun Su Chung
    Kyung Kgi Park
    Chan Dong Yom
    Dae Hoon Lee
    Byung Ha Chung
    [J]. World Journal of Urology, 2012, 30 : 265 - 269
  • [10] Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2-10 ng/mL and PSA >10 ng/mL: Results from a Multicenter Study in China
    Na, Rong
    Ye, Dingwei
    Qi, Jun
    Liu, Fang
    Helfand, Brian T.
    Brendler, Charles B.
    Conran, Carly A.
    Packiam, Vignesh
    Gong, Jian
    Wu, Yishuo
    Zheng, Siqun L.
    Mo, Zengnan
    Ding, Qiang
    Sun, Yinghao
    Xu, Jianfeng
    [J]. PROSTATE, 2017, 77 (11): : 1221 - 1229
12345